|
|
Article: Bayer Schering Pharma Presents Innovations in Men's Healthcare at the 22nd Annual Meeting of the European Association of Urology (EAU).
- Article from:
- PR Newswire
- Article date:
- March 22, 2007
|
Copyright informationCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BERLIN, Germany, March 22 /PRNewswire/ -- Bayer Schering Pharma AG, Germany, highlighted their expanded new offerings in Men's Healthcare during a press conference held at the 22nd Annual Meeting of the European Association of Urology (EAU) on March 22, 2007. The event focused on study results from their three products: Levitra(R), Testogel(R) and Nebido(R).
The Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra(R) Therapy (REPEAT) study(1) has been designed to help researchers determine why over 50 of couples experiencing sexual problems discontinue treatment. This three year, innovative post marketing surveillance (PMS) study will follow men ...